Michael Mayer

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European cooperative Crohn's disease study VI

Herbert Lochs, Michael Mayer, Wolfgang E. Fleig et al. · Gastroenterology · 2000 · 302 citations · Full text

Gastroenterology, Disease Study Vi, Postoperative Relapse +4

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

Roger Stupp, Michael Mayer, Roger Kann et al. · The Lancet Oncology · 2009 · 119 citations

Surgical Oncology, Medicine, Bronchial Neoplasm +7

Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03)

Gianfranco Pesce, Dirk Klingbiel, Karin Ribi et al. · European Journal of Cancer · 2011 · 77 citations

Neuro-oncology, Radiation Therapy, Medicine +11

Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03

G. D’Addario, Daniel Rauch, Roger Stupp et al. · Annals of Oncology · 2007 · 41 citations · Full text

Medicine, Metronomic Therapy, Gefitinib First-line Therapy +6

Bevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19/05)

Francesco Zappa, C. Droege, Daniel Betticher et al. · Lung Cancer · 2012 · 32 citations

First-line Therapy, Sakk 19/05, Medicine +8